Skip to main content
. 2016 Feb 11;11(2):e0148728. doi: 10.1371/journal.pone.0148728

Table 3. Single items of scores in survivors and non-survivors (30-day mortality in patients with acute pulmonary embolism).

Items are sorted in order of ascending p-value.

survivor* (n = 326) non-survivor* (n = 39) p-value
mean arterial pressure [mm Hg] 80 (73–91) 66 (56–79) <0.0001
systolic blood pressure [mm Hg] 111 (100–125) 94 (78–111) <0.0001
respiratory rate [breaths per minute] 23 (21–23) 25 (23–31) <0.0001
pH arterial [] 7.431 (7.400–7.475) 7.334 (7.156–7.468) <0.0001
critical preoperative state [yes / no]
» post cardiac massage [yes / no] 6% (19) 56% (22) <0.0001
» mechanical ventilation [yes / no] 12% (38) 77% (30) <0.0001
» inotropes or intra aortal balloon pump [yes / no] 13% (42) 67% (26) <0.0001
» acute renal failure (anuria or oliguria <10ml / hour) [yes / no] 6% (19) 28% (11) <0.0001
» ventricular tachycardia or ventricular fibrillation or aborted sudden death [yes / no] 13% (44) 28% (11) 0.0152
heart rate [beats per minute] 106 (90–119) 120 (100–130) 0.0018
potassium K+ (serum) [mmol/l] 4.1 (3.8–4.6) 4.3 (4.0–5.1) 0.0034
Chronic health points
» organ insufficiency [yes / no] 54% (175) 77% (30) 0.0057
» post emergency surgery [yes / no] 8% (25) 18% (7) 0.0319
» no previous surgery [yes / no] 77% (252) 69% (27) 0.2617
» post elective surgery [yes / no] 17% (57) 18% (7) 0.9425
left ventricular ejection fraction (LVEF)
» LVEF ≥ 50% 69% (226) 51% (20) 0.0231
» LVEF < 50% 31% (100) 49% (19) 0.0231
» LVEF < 30% 6% (21) 15% (6) 0.0437
» LVEF < 20% 2% (7) 5% (2) 0.2566
chronic lung disease [yes / no] 17% (54) 31% (12) 0.0293
creatinine [μmol/l] 92 (76–111) 120 (86–154) 0.0915
Saturation [%] 92 (87–97) 92 (85–98) 0.0440
extracardiac arteriopathy [yes / no]
» claudication [yes / no] 6% (20) 13% (5) 0.1182
» previous or planned intervention on the abdominal aorta, limb arteries or carotids [yes / no] 10% (31) 13% (5) 0.5121
» carotid occlusion or >50% stenosis [yes / no] 3% (10) 3% (1) 0.8620
» amputation for arterial disease [yes / no] 0% (0) 0% (0) N/A
angina at rest [yes / no] 14% (46) 5% (2) 0.1167
hematocrit [%] 38 (32–41) 35 (31–40) 0.1491
age [years] 63 (53–75) 67 (58–76) 0.1533
poor mobility [yes / no] 17% (55) 26% (10) 0.1760
active endocarditis [yes / no] 1% (2) 3% (1) 0.2022
History of cancer [yes / no] 29% (96) 38% (15) 0.2475
white blood cell count (x1000) 10.0 (8.5–12.5) 13.5 (10.0–18.6) 0.3016
NYHA
» NYHA I 16% (51) 10% (4) 0.3740
» NYHA II to IV 43% (140) 44% (17) 0.9387
» NYHA III to IV 27% (88) 21% (8) 0.3849
» NYHA IV 11% (35) 13% (5) 0.6937
sodium Na+ (serum) [mmol/l] 138 (136–140) 138 (134–140) 0.4056
temperature (rectal) [°C] 37.0 (36.9–37.5) 37.0 (36.5–37.8) 0.5034
diabetes [yes / no] 29% (93) 33% (13) 0.5320
previous cardiac surgery [yes / no] 8% (26) 10% (4) 0.6240
recent myocardial infarction [yes / no] 6% (21) 8% (3) 0.7658
severe pulmonary hypertension (> 55 mm Hg) [yes / no] 14% (47) 13% (5) 0.7874
Male sex [yes / no] 49% (159) 49% (19) 0.9948

*Median (25%–75% interquartile range) of metric variables and percent (number) of categorical variables.

subitems (grey underground) were kept together and ranked according to the subitem with the lowest p-value.